TickerFacts.

BioNexus Gene Lab Corp (BGLC): Gross Profit

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2019-12-31, 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$1.09M
Year ended 2025-12-31
$385.9K
Trailing 12 months to 2026-06-30
-4.8%
3-year compound annual growth
$2.27M2018-12-31: $28.8K2019-12-31: $55.9K2020-12-31: $1.72M2021-12-31: $2.27M2022-12-31: $1.26M2023-12-31: $1.33M2024-12-31: $1.29M2025-12-31: $1.09M$1.09M
2018-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$1.09M-15.8%2026-04-14, From 2025-01-01
2024-12-31$1.29M-3.0%2026-04-14, From 2024-01-01
2023-12-31$1.33M+5.6%2025-04-15, From 2023-01-01
2022-12-31$1.26M-44.5%2024-04-16, From 2022-01-01
2021-12-31$2.27Mn/c2023-03-31, From 2021-01-01
2020-12-31$1.72Mn/m2022-04-06, From 2020-01-01
2019-12-31$55.9Kn/c2021-03-30, From 2019-01-01
2018-12-31$28.8Kn/a2020-03-31, From 2018-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
BioNexus Gene Lab Corp (BGLC)2025-12-31$1.09M-15.8%
American Shared Hospital Services (AMS)2025-12-31$5.06M-44.9%
Exagen Inc. (XGN)2025-12-31$38.80M+17.2%
Personalis, Inc. (PSNL)2025-12-31$15.78M-41.2%
YD Bio Ltd (YDES)2025-12-31$167.4K+7.8%
BillionToOne, Inc. (BLLN)2025-12-31$208.46M+157.6%
Fulgent Genetics, Inc. (FLGT)2025-12-31$130.88M+22.1%
Castle Biosciences Inc (CSTL)2025-12-31$273.20M+0.5%
Veracyte, Inc. (VCYT)2025-12-31$362.53M+21.6%

Compare BGLC, AMS, XGN, PSNL side by side · Screen every company in Services-Medical Laboratories ↗